• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    President, Worksite Division Detoro Karen J. sold $973,018 worth of Common Stock (25,657 units at $37.92), decreasing direct ownership by 38% to 41,855 units (SEC Form 4)

    8/15/25 4:28:55 PM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    DeToro Karen J.

    (Last) (First) (Middle)
    C/O CNO FINANCIAL GROUP, INC.
    11299 ILLINOIS STREET, SUITE 200

    (Street)
    CARMEL IN 46032

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CNO Financial Group, Inc. [ CNO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    President, Worksite Division
    3. Date of Earliest Transaction (Month/Day/Year)
    08/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 08/13/2025 S 9,920(1) D $37.9588(2) 57,592 D
    Common Stock 08/14/2025 S 6,509(1) D $37.9788(3) 51,083 D
    Common Stock 08/15/2025 S 9,228(1) D $37.8481(4) 41,855 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 6, 2025.
    2. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.82 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    3. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.79 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    4. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.68 per share to $38.24 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    Remarks:
    Heidi. M. Krings, Attorney-in-Fact 08/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CNO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    1/5/2022$29.00 → $27.00Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $CNO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Worksite Division Detoro Karen J. sold $973,018 worth of Common Stock (25,657 units at $37.92), decreasing direct ownership by 38% to 41,855 units (SEC Form 4)

    4 - CNO Financial Group, Inc. (0001224608) (Issuer)

    8/15/25 4:28:55 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    Amendment: President, Worksite Division Detoro Karen J. covered exercise/tax liability with 1,417 units of Common Stock, decreasing direct ownership by 2% to 58,918 units (SEC Form 4)

    4/A - CNO Financial Group, Inc. (0001224608) (Issuer)

    8/15/25 4:07:39 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    Chief Operations Officer Linnenbringer Jeanne L. exercised 4,420 units of Common Stock at a strike of $21.06 and sold $559,204 worth of Common Stock (14,739 units at $37.94), decreasing direct ownership by 25% to 30,844 units (SEC Form 4)

    4 - CNO Financial Group, Inc. (0001224608) (Issuer)

    8/15/25 4:04:54 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CNO Financial Group Declares $0.17 Quarterly Dividend

    CARMEL, Ind., Aug. 6, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.17 per share on the company's common shares. The dividend will be payable September 24, 2025, to shareholders of record at the close of business on September 10, 2025. About CNO Financial GroupCNO Financial Group, Inc. (NYSE:CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services and workforce benefits solutions through our family of brands, includ

    8/6/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Reports Second Quarter 2025 Results

    Strong production; Solid financial results; On track to deliver 2025-2027 ROE targets CARMEL, Ind., July 28, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) today reported net income of $91.8 million, or $0.91 per diluted share, in 2Q25 compared to $116.3 million or $1.06 per diluted share, in 2Q24. Non-economic accounting impacts due to market volatility increased net income in both 2Q25 and 2Q24. Net operating income,(1) which excludes these non-economic accounting impacts, was $87.5 million, or $0.87 per diluted share, in 2Q25 compared to $114.6 million, or $1.05 per diluted share, in 2Q24.

    7/28/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group to Release Second Quarter Results on July 28, 2025

    CARMEL, Ind., July 14, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) will report results for the second quarter of 2025 after the market closes on Monday, July 28, 2025. The company will host a conference call to discuss results at 11:00 a.m. Eastern Time on Tuesday, July 29, 2025. Participate by Dial-InTo participate, please register here. Upon registering, you will be provided with call details and a registrant ID that is used to track attendance on the conference call. Reminders will also be sent to registered participants via email. Participate by WebcastFor th

    7/14/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on CNO Financial with a new price target

    BMO Capital Markets initiated coverage of CNO Financial with a rating of Market Perform and set a new price target of $38.00

    1/23/25 7:38:32 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded CNO Financial from Neutral to Overweight and set a new price target of $29.00

    4/16/24 7:43:21 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded CNO Financial from In-line to Underperform and set a new price target of $26.00 from $24.00 previously

    1/4/24 8:13:08 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    SEC Filings

    View All

    SEC Form S-8 filed by CNO Financial Group Inc.

    S-8 - CNO Financial Group, Inc. (0001224608) (Filer)

    8/8/25 4:50:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form S-8 filed by CNO Financial Group Inc.

    S-8 - CNO Financial Group, Inc. (0001224608) (Filer)

    8/8/25 4:47:53 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form 13F-HR filed by CNO Financial Group Inc.

    13F-HR - CNO Financial Group, Inc. (0001224608) (Filer)

    8/8/25 11:37:26 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Leadership Updates

    Live Leadership Updates

    View All

    CNO Financial Group Announces Voting Results from 2025 Annual Meeting of Shareholders

    CARMEL, Ind., May 8, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced that at the company's annual meeting held earlier today, its shareholders: Elected nine directors (Gary C. Bhojwani, Archie M. Brown, David B. Foss, Mary R. (Nina) Henderson, Adrianne B. Lee, Daniel R. Maurer, Chetlur S. Ragavan, Steven E. Shebik, and Jessica A. Turner) to each serve a one-year term expiring at next year's annual meeting.Approved, by non-binding advisory vote, the executive compensation of the company's named executive officers as disclosed in the proxy statement for the a

    5/8/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Appoints Jess Turner to its Board of Directors

    CARMEL, Ind., Oct. 1, 2024 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its board of directors has appointed Jess Turner as a director, effective immediately. Turner is Executive Vice President and Global Head of Open Banking and API at Mastercard (NYSE:MA), a global technology company in the payments industry, and is a member of its Management Committee. Turner's appointment increases the size of the CNO board to nine directors. "We are very pleased to welcome Jess to CNO's board of directors," said Board Chair Dan Maurer. "As a senior technology

    10/1/24 5:00:00 PM ET
    $CNO
    $MA
    Accident &Health Insurance
    Finance
    Real Estate

    CNO Financial Group Announces Results from 2024 Annual Shareholder Meeting

    CARMEL, Ind., May 9, 2024 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced that at the company's annual meeting held earlier today, its shareholders: Elected eight directors (Gary C. Bhojwani, Archie M. Brown, David. B. Foss, Mary R. (Nina) Henderson, Adrianne B. Lee, Daniel R. Maurer, Chetlur S. Ragavan, and Steven E. Shebik) to each serve a one-year term expiring at next year's annual meeting.Approved, by non-binding advisory vote, the executive compensation of the company's named executive officers as disclosed in the proxy statement for the annual meeting.Rat

    5/9/24 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CNO Financial Group Inc. (Amendment)

    SC 13G/A - CNO Financial Group, Inc. (0001224608) (Subject)

    2/12/24 5:53:46 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form SC 13G filed by CNO Financial Group Inc.

    SC 13G - CNO Financial Group, Inc. (0001224608) (Subject)

    2/9/24 11:33:46 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form SC 13G/A filed by CNO Financial Group Inc. (Amendment)

    SC 13G/A - CNO Financial Group, Inc. (0001224608) (Subject)

    2/14/23 12:24:22 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Financials

    Live finance-specific insights

    View All

    CNO Financial Group Declares $0.17 Quarterly Dividend

    CARMEL, Ind., Aug. 6, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.17 per share on the company's common shares. The dividend will be payable September 24, 2025, to shareholders of record at the close of business on September 10, 2025. About CNO Financial GroupCNO Financial Group, Inc. (NYSE:CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services and workforce benefits solutions through our family of brands, includ

    8/6/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Reports Second Quarter 2025 Results

    Strong production; Solid financial results; On track to deliver 2025-2027 ROE targets CARMEL, Ind., July 28, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) today reported net income of $91.8 million, or $0.91 per diluted share, in 2Q25 compared to $116.3 million or $1.06 per diluted share, in 2Q24. Non-economic accounting impacts due to market volatility increased net income in both 2Q25 and 2Q24. Net operating income,(1) which excludes these non-economic accounting impacts, was $87.5 million, or $0.87 per diluted share, in 2Q25 compared to $114.6 million, or $1.05 per diluted share, in 2Q24.

    7/28/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group to Release Second Quarter Results on July 28, 2025

    CARMEL, Ind., July 14, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) will report results for the second quarter of 2025 after the market closes on Monday, July 28, 2025. The company will host a conference call to discuss results at 11:00 a.m. Eastern Time on Tuesday, July 29, 2025. Participate by Dial-InTo participate, please register here. Upon registering, you will be provided with call details and a registrant ID that is used to track attendance on the conference call. Reminders will also be sent to registered participants via email. Participate by WebcastFor th

    7/14/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance